Hi @ianwill, not sure if you expected a reply or just felt like giving me a lecture on what my goals should be.
I don't believe I referenced the sp when talking about the quality of the IP and Management, however as you raised it, it gives me no pleasure to see the current sp even if I think it is purposely held down.
Time will if the trials are successful and therefore the sp reflects true value, I am prepared to keep my funds invested until we know these results.
DYOR opinion only
Ann: Imugene onCARlytics Doses First Patient in IV Combination, page-211
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
